(63 days)
Breas HA50 (K002454)
Not Found
No
The description details a standard pass-over humidifier with electronic heating controlled by software in the connected breathing unit. There is no mention of AI, ML, or any learning or adaptive capabilities.
Yes
The device is intended to humidify gases delivered to a patient receiving CPAP or bilevel ventilator therapy, which are forms of breathing therapy. Humidity is an important component of respiratory treatment.
No
Explanation: The device is a humidifier intended to humidify gases for patients using CPAP or bilevel ventilators. Its function is therapeutic, not diagnostic.
No
The device description clearly outlines physical components like a water container and an electronic heating unit, indicating it is a hardware device with integrated software control.
Based on the provided information, the Breas HA01 is not an IVD (In Vitro Diagnostic) device.
Here's why:
- Intended Use: The intended use is to humidify gases delivered to a patient during breathing therapy (CPAP or bilevel ventilation). This is a therapeutic function, not a diagnostic one.
- Device Description: The description details a humidifier that adds moisture to air for breathing. It does not involve analyzing biological samples (blood, urine, tissue, etc.) which is the core function of an IVD.
- Lack of IVD Characteristics: There is no mention of analyzing samples, detecting biomarkers, or providing diagnostic information.
Therefore, the Breas HA01 falls under the category of a medical device used for respiratory therapy, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Breas HA01 is a humidifier intended to humidify gases delivered to a patient with a Breas CPAP device or a bilevel ventilator constructed to use an internal mask leak and no active exhalation valve.
Product codes (comma separated list FDA assigned to the subject device)
BTT
Device Description
The HA01 is a humidifier that only can be used together with Breas breathing therapy equipment. such as iSleep or Viyo. It uses pass-over humidification to humidify the air delivered to the patient.
It consists of the following major components:
1 Water container - a sealed container with a water capacity of 400 ml. It has one inlet port where the air from the ventilator enters the humidifier and one 22 mm standard conical male outlet port where various non-invasive patient interfaces, such as nasal masks may be connected. It has a detachable lid that is removed when filling water in the container. The water container is attached to other Breathing therapy equipment, such as iSleep or Vivo when in use. Dimensions: W × H × D148 × 155 × 98 mm Weight; 260 g (empty container)
2 Electronic heating unit that via a heating plate heats the water container. Power. 12-30 V DC. max 40 W. is supplied from the Breas breathing therapy unit that the humidifier is connected to. The output from the HA01 unit is controlled by software included in the attached Breas unit. This software, which is a modularized part of the connected unit, controls temperature and it includes alarm supervision.
The Breas HA01 may, together with other Breas breathing therapy equipment such as iSleep or Vivo, be used in clinical settings (e.g., hospitals, sleep laboratories, sub-acute care institutions) and home environments. It must always be prescribed by a licensed physician.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
The Breas HA01 may, together with other Breas breathing therapy equipment such as iSleep or Vivo, be used in clinical settings (e.g., hospitals, sleep laboratories, sub-acute care institutions) and home environments. It must always be prescribed by a licensed physician.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
- Non-clinical testing was conducted to verify that the Breas HA01 is capable of meeting its stated performance specifications and that all Risk Analysis issues have been appropriately addressed. The device passed all tests.
- Comparative testing to predicate device has been performed, both devices were tested according to ISO 8185. This bench testing confirmed that the HA01 is substantial equivalent to its predicate device.
- Testing was conducted to demonstrate compliance with applicable requirements in the November 1993 draft "Reviewer Guidance for Premarket Notification Submissions" published by the FDA's Division of Cardiovascular, Respiratory, and Neurological Devices and the July 1995 "Draft Reviewer Guidance for Ventilators". The testing included but was not limited to:
- Electrical Safety testing per IEC 60601-1
- Safety and Performance testing per ISO 17510-1
- Medical use humidifiers testing per ISO 8185
- Electromagnetic Compatibility testing (EMC testing)
- Mechanical Safety testing
- Environmental testing
- Functional testing
- Particle matter testing
The testing was performed as an integral part of the development of the Breas Vivo 30, Breas Vivo 40 and Breas iSleep 20 systems.
The device passed all tests.
- Clinical studies were not required to support a substantial equivalence determination.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Breas HA50 (K002454)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.5450 Respiratory gas humidifier.
(a)
Identification. A respiratory gas humidifier is a device that is intended to add moisture to, and sometimes to warm, the breathing gases for administration to a patient. Cascade, gas, heated, and prefilled humidifiers are included in this generic type of device.(b)
Classification. Class II (performance standards).
0
510(k) Premarket Notification
Breas Medical AB
Kobo79c
510(k) SUMMARY
MAY 2 5 2006
Submitter
Breas Medical AB
Företagsvagen 1
Karl-Johan Holm
SE 435 33 Molnlycke
Sweden
Contact Person
Summary Date
Quality Assurance and Regulatory Affairs Manager
Heated Humidifier or humidifier, respiratory gas,
(direct patient interface) (21 CFR 868.5450)
Phone: +46 31 868830
Fax: +46 31 868810
March 06, 2006
HA01 Humidifier
HA01
BTT
Name of Device
Common Name
Classification Name
Product Code
Predicate Device
Breas HA50 (K002454)
1
Device Description:
The HA01 is a humidifier that only can be used together with Breas breathing therapy equipment. such as iSleep or Viyo. It uses pass-over humidification to humidify the air delivered to the patient.
It consists of the following major components:
1 Water container - a sealed container with a water capacity of 400 ml. It has one inlet port where the air from the ventilator enters the humidifier and one 22 mm standard conical male outlet port where various non-invasive patient interfaces, such as nasal masks may be connected. It has a detachable lid that is removed when filling water in the container. The water container is attached to other Breathing therapy equipment, such as iSleep or Vivo when in use. Dimensions: W × H × D148 × 155 × 98 mm Weight; 260 g (empty container)
2 Electronic heating unit that via a heating plate heats the water container. Power. 12-30 V DC. max 40 W. is supplied from the Breas breathing therapy unit that the humidifier is connected to. The output from the HA01 unit is controlled by software included in the attached Breas unit. This software, which is a modularized part of the connected unit, controls temperature and it includes alarm supervision.
The Breas HA01 may, together with other Breas breathing therapy equipment such as iSleep or Vivo, be used in clinical settings (e.g., hospitals, sleep laboratories, sub-acute care institutions) and home environments. It must always be prescribed by a licensed physician.
Intended Use:
The Breas HA01 is a humidifier intended to humidify gases delivered to a patient with a Breas CPAP device or a bilevel ventilator constructed to use an internal mask leak and no active exhalation valve.
Comparison of Use and Technological Characteristics:
The HA01 can be used in clinical settings (e.g., hospitals, sleep laboratories, sub-acute care institutions) and home environments.
As compared with the cited predicate device, the Breas HA01 has:
Same intended uses
2
Similar design
Same fundamental scientific technology
The differences that do exist are minimal. The HA01 is intended to be used integrated with other Breas products (e.g. Breas Vivo and iSleep systems). The features are described in the modified device information section 6 and appendix 6 (manuals and sell sheets).
Summary of Performance Testing:
-
- Non-clinical testing was conducted to verify that the Breas HA01 is capable of meeting its stated performance specifications and that all Risk Analysis issues have been appropriately addressed. The device passed all tests.
-
- Comparative testing to predicate device has been performed, both devices were tested according to ISO 8185. This bench testing confirmed that the HA01 is substantial equivalent to its predicate device.
-
- Testing was conducted to demonstrate compliance with applicable requirements in the November 1993 draft "Reviewer Guidance for Premarket Notification Submissions" published by the FDA's Division of Cardiovascular, Respiratory, and Neurological Devices and the July 1995 "Draft Reviewer Guidance for Ventilators". The testing included but was not limited to:
- Electrical Safety testing per IEC 60601-1 ●
- Safety and Performance testing per ISO 17510-1 .
- . Medical use humidifiers testing per ISO 8185
- . Electromagnetic Compatibility testing (EMC testing)
- . Mechanical Safety testing
- Environmental testing .
- . Functional testing
- Particle matter testing ◆
The testing was performed as an integral part of the development of the Breas Vivo 30, Breas Vivo 40 and Breas iSleep 20 systems.
The device passed all tests.
-
- Clinical studies were not required to support a substantial equivalence determination.
3
Conclusions:
The Breas HA 01 meets its stated performance specifications and criteria outlined in the Reviewer Guidance publications referenced above. We conclude that the device is capable of operating safely in their intended environments and will be effective in fulfilling its intended use.
4
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized caduceus symbol, which features a staff with a snake winding around it. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" is arranged in a circular pattern around the symbol. The logo is black and white.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAY 2 5 2006
Mr. Karl-Johan Holm Quality Assurance & Regulatory Affairs Mananger Breas Medical AB Företagsvagen 1 Molnlycke SWEDEN SE 435 33
Re: K060790
Trade/Device Name: Breas, Model HA01 Regulation Number: 21 CFR 868.5450 Regulation Name: Respiratory Gas Humidifier Regulatory Class: II Product Code: BTT Dated: April 25, 2006 Received: May 1, 2006
Dear Mr. Holm:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
5
Page 2 - Mr. Holm
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits vour device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Signature
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
Indications for Use
510(k) Number (if known): K060790
Device Name: Breas HA01
Indications for Use:
The Breas HA01 is a humidifier intended to humidify gases delivered to a patient with a Breas CPAP device or a bilevel ventilator constructed to use an internal mask leak and no active exhalation valve.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use = (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Ausylhom
General Hospital i di Andalhesionegy, on Control, Denta
Number K060790
Page 1_of_1